Vinorelbine Injection
Generic name: Pronounced as (vi nor' el been)
Medical Content Reviewed By HelloPharmacist Staff
Last Revised - 04/15/2020
On this page
- Why is this medication prescribed?
- How should this medicine be used?
- Other uses for this medicine
- What special precautions should I follow?
- What special dietary instructions should I follow?
- What side effects can this medication cause?
- What should I do in case of OVERDOSE?
- What OTHER INFORMATION should I know?
- Other names
- Drug interactions
IMPORTANT WARNING
Vinorelbine should be given only under the supervision of a doctor with experience in the use of chemotherapy medications.
Vinorelbine can cause a severe decrease in the number of blood cells in your bone marrow. This may cause certain symptoms and may increase the risk that you will develop a serious infection. Your doctor will order laboratory tests before and during your treatment to check the number of white blood cells in your blood. Your doctor may decrease your dose, or delay,, interrupt, or stop your treatment if the number of white blood cells is too low. If you experience any of the following symptoms, call your doctor immediately: fever, sore throat, ongoing cough and congestion, or other signs of infection.
Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your body's response to vinorelbine.
Why is this medication prescribed?
Vinorelbine is used alone and in combination with other medications to treat non-small cell lung cancer (NSCLC) that has spread to nearby tissues or to other parts of the body. Vinorelbine is in a class of medications called vinca alkaloids. It works by slowing or stopping the growth of cancer cells in your body.
How should this medicine be used?
Vinorelbine comes as a solution (liquid) to be injected intravenously (into a vein) by a doctor or nurse in a medical facility. It is usually given once a week. The length of treatment depends on how well your body responds to treatment with vinorelbine.
You should know that vinorelbine should be administered only into a vein. However, it may leak into surrounding tissue causing severe irritation or damage. Your doctor or nurse will monitor the area near where the medication was injected. If you experience any of the following symptoms, tell your doctor immediately: pain, itching, redness, swelling, blisters, or sores near the place where the medication was injected.
Other uses for this medicine
Vinorelbine is also sometimes used to treat breast cancer, cancer of the esophagus (tube that connects the mouth and stomach), and soft tissue sarcomas (cancer that forms in muscles). Talk to your doctor about the risks of using this medication for your condition.
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before receiving vinorelbine,
-
tell your doctor and pharmacist if you are allergic to vinorelbine, any other medications, or any of the ingredients in vinorelbine injection. Ask your pharmacist for a list of the ingredients.
-
tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: certain antifungals such as itraconazole (Onmel, Sporanox, Tolsura) and ketoconazole; clarithromycin ; HIV protease inhibitors including indinavir (Crixivan), nelfinavir (Viracept), ritonavir (Norvir, in Kaletra, Technivie, Viekira), and saquinavir (Invirase); or nefazodone. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
-
tell your doctor if you have or have ever had liver disease.
-
Tell your doctor if you are pregnant, plan to become pregnant,, or plan to father a child. You or your partner should not become pregnant while you are receiving vinorelbine injection. You must take a pregnancy test before you start treatment to be sure you are not pregnant. If you are a female, use effective birth control during your treatment and for 6 months after your final dose. If you are a male, use effective birth control during your treatment and for 3 months after your final dose. If you or your partner become pregnant while you're receiving vinorelbine injection, call your doctor. Vinorelbine may harm the fetus.
-
tell your doctor if you are breast-feeding. Your doctor will probably tell you not to breastfeed during your treatment and for 9 days after your final dose.
-
you should know that vinorelbine may cause constipation. Talk to your doctor about changing your diet and using other medications to prevent or treat constipation while you are taking vinorelbine.
What special dietary instructions should I follow?
Your doctor may tell you to be sure to drink enough of water, and eat high fiber foods such as lettuce, spinach, broccoli, squashes, beans, nuts, seeds, fruit, whole wheat bread, whole wheat pasta, or brown rice. Be sure to follow the instructions carefully.
What side effects can this medication cause?
-
Vinorelbine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
-
nausea
-
vomiting
-
diarrhea
-
loss of appetite
-
weight loss
-
change in ability to taste food
-
sores in the mouth and throat
-
hearing loss
-
muscle, or joint pain
-
hair loss
-
lack of energy, not feeling well, tiredness
-
-
Some side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING section, call your doctor immediately or get emergency medical treatment:
-
shortness of breath or difficulty breathing, cough
-
constipation, stomach pain, nausea, vomiting
-
unusual bleeding or bruising
-
hives, itching, rash, difficulty breathing or swallowing
-
swelling of the face, throat, tongue, lips, and eyes
-
blistering or peeling skin
-
yellowing of skin or eyes, dark colored urine, light colored stool
-
numbness, tingling feeling on skin, sensitive skin, decreased sense of touch, or muscle weakness
-
fever, chills, sore throat or other signs of infection
-
chest pain, shortness of breath, coughing up blood
-
red, swollen, tender, or warm arm or leg
-
-
Talk to your doctor about the risks of receiving vinorelbine injection.
-
Vinorelbine may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
-
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
What should I do in case of OVERDOSE?
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
Symptoms of overdose may include:
-
sores in the mouth and throat
-
stomach pain
-
constipation
-
fever, sore throat, chills, or other signs of infection
-
loss of the ability to move muscles and to feel a part of the body
What OTHER INFORMATION should I know?
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Drug interactions
Drug | Interaction |
---|---|
Leflunomide | Leflunomide The risk or severity of adverse effects can be increased when Vinorelbine is combined with Leflunomide. |
Delavirdine | Delavirdine The metabolism of Delavirdine can be decreased when combined with Vinorelbine. |
Nevirapine | Nevirapine The metabolism of Nevirapine can be decreased when combined with Vinorelbine. |
Dolasetron | Dolasetron The metabolism of Dolasetron can be decreased when combined with Vinorelbine. |
Anagrelide | Anagrelide The risk or severity of bleeding can be increased when Anagrelide is combined with Vinorelbine. |
Cilostazol | Cilostazol The metabolism of Cilostazol can be decreased when combined with Vinorelbine. |
Clopidogrel | Clopidogrel The risk or severity of bleeding can be increased when Clopidogrel is combined with Vinorelbine. |
Erythromycin and Sulfisoxazole | Erythromycin and Sulfisoxazole The metabolism of Vinorelbine can be decreased when combined with Erythromycin. |
Fenofibrate | Fenofibrate The metabolism of Vinorelbine can be decreased when combined with Fenofibrate. |
Methylergonovine | Methylergonovine The metabolism of Vinorelbine can be decreased when combined with Methylergometrine. |
Mycophenolate | Mycophenolate The risk or severity of adverse effects can be increased when Vinorelbine is combined with Mycophenolic acid. |
Penbutolol | Penbutolol The metabolism of Acebutolol can be decreased when combined with Vinorelbine. |
Prednisone | Prednisone The risk or severity of adverse effects can be increased when Vinorelbine is combined with Prednisone. |
Reserpine | Reserpine Reserpine may increase the neurotoxic activities of Vinorelbine. |
Tacrolimus | Tacrolimus Tacrolimus may increase the immunosuppressive activities of Vinorelbine. |
Triamcinolone | Triamcinolone The metabolism of Triamcinolone can be increased when combined with Vinorelbine. |
Doxycycline Injection | Doxycycline Injection The metabolism of Vinorelbine can be decreased when combined with Doxycycline. |
Fluconazole Injection | Fluconazole Injection The metabolism of Vinorelbine can be decreased when combined with Fluconazole. |
Interferon Beta-1b Injection | Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Vinorelbine. |
Interferon Gamma-1b Injection | Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vinorelbine. |
Meperidine Injection | Meperidine Injection The metabolism of Meperidine can be increased when combined with Vinorelbine. |
Methylprednisolone Injection | Methylprednisolone Injection The metabolism of Methylprednisolone can be increased when combined with Vinorelbine. |
Metoclopramide Injection | Metoclopramide Injection The metabolism of Metoclopramide can be decreased when combined with Vinorelbine. |
Metronidazole Injection | Metronidazole Injection The metabolism of Vinorelbine can be decreased when combined with Metronidazole. |
Zidovudine Injection | Zidovudine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Zidovudine. |
Altretamine | Altretamine The metabolism of Amphetamine can be decreased when combined with Vinorelbine. |
Cyclosporine | Cyclosporine Vinorelbine may increase the immunosuppressive activities of Cyclosporine. |
Ondansetron | Ondansetron The metabolism of Ondansetron can be decreased when combined with Vinorelbine. |
Enoxaparin Injection | Enoxaparin Injection The risk or severity of bleeding can be increased when Enoxaparin is combined with Vinorelbine. |
Olanzapine | Olanzapine The metabolism of Olanzapine can be decreased when combined with Vinorelbine. |
Hydroxychloroquine | Hydroxychloroquine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Hydroxychloroquine. |
Orlistat | Orlistat The metabolism of Vinorelbine can be increased when combined with Orlistat. |
Oxcarbazepine | Oxcarbazepine The metabolism of Vinorelbine can be increased when combined with Oxcarbazepine. |
Temozolomide | Temozolomide The risk or severity of adverse effects can be increased when Vinorelbine is combined with Temozolomide. |
Anakinra | Anakinra The metabolism of Vinorelbine can be increased when combined with Anakinra. |
Linezolid | Linezolid The risk or severity of adverse effects can be increased when Vinorelbine is combined with Linezolid. |
Pentosan Polysulfate | Pentosan Polysulfate The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Vinorelbine. |
Trimipramine | Trimipramine The metabolism of Trimipramine can be decreased when combined with Vinorelbine. |
Etanercept Injection | Etanercept Injection The metabolism of Vinorelbine can be increased when combined with Etanercept. |
Modafinil | Modafinil The metabolism of Vinorelbine can be increased when combined with Modafinil. |
Tenofovir | Tenofovir The metabolism of Vinorelbine can be decreased when combined with Tenofovir. |
Sirolimus | Sirolimus The risk or severity of adverse effects can be increased when Vinorelbine is combined with Sirolimus. |
Epinephrine Injection | Epinephrine Injection The metabolism of Vinorelbine can be decreased when combined with Epinephrine. |
Epirubicin | Epirubicin The risk or severity of adverse effects can be increased when Vinorelbine is combined with Epirubicin. |
Escitalopram | Escitalopram The metabolism of Escitalopram can be decreased when combined with Vinorelbine. |
Adalimumab Injection | Adalimumab Injection The metabolism of Vinorelbine can be increased when combined with Adalimumab. |
Aripiprazole | Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Vinorelbine. |
Atomoxetine | Atomoxetine The metabolism of Atomoxetine can be decreased when combined with Vinorelbine. |
Glatiramer Injection | Glatiramer Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Glatiramer. |
Atazanavir | Atazanavir The metabolism of Vinorelbine can be decreased when combined with Atazanavir. |
Almotriptan | Almotriptan The metabolism of Almotriptan can be decreased when combined with Vinorelbine. |
Eletriptan | Eletriptan The metabolism of Eletriptan can be decreased when combined with Vinorelbine. |
Mefloquine | Mefloquine The metabolism of Vinorelbine can be decreased when combined with Mefloquine. |
Rosuvastatin | Rosuvastatin The metabolism of Vinorelbine can be decreased when combined with Rosuvastatin. |
Aprepitant | Aprepitant The metabolism of Vinorelbine can be decreased when combined with Aprepitant. |
Tegaserod | Tegaserod The metabolism of Tegaserod can be decreased when combined with Vinorelbine. |
Progesterone | Progesterone The metabolism of Progesterone can be increased when combined with Vinorelbine. |
Darbepoetin Alfa Injection | Darbepoetin Alfa Injection The risk or severity of peripheral neuropathy can be increased when Darbepoetin alfa is combined with Vinorelbine. |
Infliximab Injection | Infliximab Injection The metabolism of Vinorelbine can be increased when combined with Infliximab. |
Protriptyline | Protriptyline The metabolism of Protriptyline can be decreased when combined with Vinorelbine. |
Rifaximin | Rifaximin The metabolism of Vinorelbine can be increased when combined with Rifaximin. |
Duloxetine | Duloxetine The metabolism of Duloxetine can be decreased when combined with Vinorelbine. |
Norethindrone | Norethindrone The metabolism of Vinorelbine can be decreased when combined with Norethisterone. |
Bosentan | Bosentan The metabolism of Vinorelbine can be increased when combined with Bosentan. |
Natalizumab Injection | Natalizumab Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Natalizumab. |
Erlotinib | Erlotinib The metabolism of Erlotinib can be decreased when combined with Vinorelbine. |
Palifermin | Palifermin The therapeutic efficacy of Palifermin can be decreased when used in combination with Vinorelbine. |
Solifenacin | Solifenacin The metabolism of Solifenacin can be decreased when combined with Vinorelbine. |
Voriconazole | Voriconazole The metabolism of Vinorelbine can be decreased when combined with Voriconazole. |
Dextroamphetamine | Dextroamphetamine The metabolism of Amphetamine can be decreased when combined with Vinorelbine. |
Peginterferon Alfa-2a Injection | Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vinorelbine. |
Peginterferon Alfa-2b (PEG-Intron) | Peginterferon Alfa-2b (PEG-Intron) The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vinorelbine. |
Darifenacin | Darifenacin The metabolism of Darifenacin can be decreased when combined with Vinorelbine. |
Deferasirox | Deferasirox The metabolism of Vinorelbine can be increased when combined with Deferasirox. |
Tipranavir | Tipranavir The metabolism of Tipranavir can be decreased when combined with Vinorelbine. |
Felbamate | Felbamate The metabolism of Vinorelbine can be increased when combined with Felbamate. |
Ranolazine | Ranolazine The metabolism of Ranolazine can be decreased when combined with Vinorelbine. |
Abatacept Injection | Abatacept Injection The metabolism of Abatacept can be increased when combined with Vinorelbine. |
Imatinib | Imatinib The metabolism of Imatinib can be decreased when combined with Vinorelbine. |
Bevacizumab Injection | Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Vinorelbine. |
Gefitinib | Gefitinib Gefitinib may increase the neutropenic activities of Vinorelbine. |
Paliperidone | Paliperidone The metabolism of Paliperidone can be decreased when combined with Vinorelbine. |
Bortezomib | Bortezomib The risk or severity of adverse effects can be increased when Bortezomib is combined with Vinorelbine. |
Clofarabine Injection | Clofarabine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Clofarabine. |
Hepatitis B Vaccine | Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Vinorelbine. |
Influenza Vaccine, Inactivated or Recombinant | Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Vinorelbine. |
Influenza Vaccine, Live Intranasal | Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Vinorelbine. |
Live Shingles (Zoster) Vaccine (ZVL) | Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Vinorelbine. |
Oxaliplatin Injection | Oxaliplatin Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Oxaliplatin. |
Posaconazole | Posaconazole The metabolism of Vinorelbine can be decreased when combined with Posaconazole. |
Primaquine | Primaquine The metabolism of Vinorelbine can be decreased when combined with Primaquine. |
Rituximab Injection | Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Vinorelbine. |
Bismuth Subsalicylate | Bismuth Subsalicylate Vinorelbine may increase the neurotoxic activities of Bismuth subsalicylate. |
Darunavir | Darunavir The serum concentration of Vinorelbine can be increased when it is combined with Darunavir. |
Pemetrexed Injection | Pemetrexed Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Pemetrexed. |
Lisdexamfetamine | Lisdexamfetamine The metabolism of Lisdexamfetamine can be decreased when combined with Vinorelbine. |
Vorinostat | Vorinostat The risk or severity of adverse effects can be increased when Vinorelbine is combined with Vorinostat. |
Sorafenib | Sorafenib The metabolism of Sorafenib can be decreased when combined with Vinorelbine. |
Sunitinib | Sunitinib The metabolism of Sunitinib can be decreased when combined with Vinorelbine. |
Lapatinib | Lapatinib The metabolism of Vinorelbine can be decreased when combined with Lapatinib. |
Pegfilgrastim Injection | Pegfilgrastim Injection The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vinorelbine. |
Dasatinib | Dasatinib The metabolism of Dasatinib can be decreased when combined with Vinorelbine. |
Mexiletine | Mexiletine The metabolism of Mexiletine can be decreased when combined with Vinorelbine. |
Armodafinil | Armodafinil The metabolism of Vinorelbine can be increased when combined with Armodafinil. |
Azacitidine Injection | Azacitidine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Azacitidine. |
Ivermectin | Ivermectin The metabolism of Vinorelbine can be increased when combined with Ivermectin. |
Temsirolimus | Temsirolimus The risk or severity of adverse effects can be increased when Vinorelbine is combined with Temsirolimus. |
Nelarabine Injection | Nelarabine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Nelarabine. |
Lenalidomide | Lenalidomide The risk or severity of adverse effects can be increased when Vinorelbine is combined with Lenalidomide. |
Nilotinib | Nilotinib The metabolism of Nilotinib can be decreased when combined with Vinorelbine. |
Bexarotene | Bexarotene The metabolism of Vinorelbine can be increased when combined with Bexarotene. |
Budesonide | Budesonide The metabolism of Budesonide can be increased when combined with Vinorelbine. |
Chloramphenicol Injection | Chloramphenicol Injection The metabolism of Chloramphenicol can be decreased when combined with Vinorelbine. |
Decitabine Injection | Decitabine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Decitabine. |
Etravirine | Etravirine The metabolism of Vinorelbine can be increased when combined with Etravirine. |
Arsenic Trioxide Injection | Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Arsenic trioxide. |
Mitoxantrone Injection | Mitoxantrone Injection The metabolism of Mitoxantrone can be decreased when combined with Vinorelbine. |
Desvenlafaxine | Desvenlafaxine The metabolism of Vinorelbine can be decreased when combined with Desvenlafaxine. |
Cevimeline | Cevimeline The metabolism of Cevimeline can be decreased when combined with Vinorelbine. |
Nebivolol | Nebivolol The metabolism of Nebivolol can be decreased when combined with Vinorelbine. |
Tretinoin | Tretinoin The risk or severity of adverse effects can be increased when Vinorelbine is combined with Tretinoin. |
Bendamustine Injection | Bendamustine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Bendamustine. |
Pilocarpine | Pilocarpine The metabolism of Vinorelbine can be decreased when combined with Pilocarpine. |
Flecainide | Flecainide The metabolism of Flecainide can be decreased when combined with Vinorelbine. |
Certolizumab Injection | Certolizumab Injection The metabolism of Certolizumab pegol can be increased when combined with Vinorelbine. |
Ixabepilone Injection | Ixabepilone Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Ixabepilone. |
Irinotecan Injection | Irinotecan Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Irinotecan. |
Estramustine | Estramustine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Estramustine. |
Mitotane | Mitotane The metabolism of Vinorelbine can be increased when combined with Mitotane. |
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) | Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Vinorelbine. |
Rufinamide | Rufinamide The metabolism of Vinorelbine can be increased when combined with Rufinamide. |
Midazolam | Midazolam The metabolism of Vinorelbine can be decreased when combined with Midazolam. |
Romiplostim Injection | Romiplostim Injection The risk or severity of peripheral neuropathy can be increased when Romiplostim is combined with Vinorelbine. |
Dexrazoxane Injection | Dexrazoxane Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Dexrazoxane. |
Ibritumomab Injection | Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Vinorelbine. |
Milnacipran | Milnacipran The metabolism of Vinorelbine can be decreased when combined with Milnacipran. |
Fesoterodine | Fesoterodine The metabolism of Fesoterodine can be decreased when combined with Vinorelbine. |
Betaxolol | Betaxolol The metabolism of Betaxolol can be decreased when combined with Vinorelbine. |
Iloperidone | Iloperidone The metabolism of Iloperidone can be decreased when combined with Vinorelbine. |
Prasugrel | Prasugrel The risk or severity of bleeding can be increased when Prasugrel is combined with Vinorelbine. |
Lacosamide | Lacosamide The metabolism of Vinorelbine can be decreased when combined with Lacosamide. |
Everolimus | Everolimus The risk or severity of adverse effects can be increased when Vinorelbine is combined with Everolimus. |
Dronedarone | Dronedarone The serum concentration of Vinorelbine can be increased when it is combined with Dronedarone. |
Pralatrexate Injection | Pralatrexate Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Pralatrexate. |
Palonosetron Injection | Palonosetron Injection The metabolism of Palonosetron can be decreased when combined with Vinorelbine. |
Tapentadol | Tapentadol The metabolism of Tapentadol can be decreased when combined with Vinorelbine. |
Topotecan | Topotecan The metabolism of Topotecan can be increased when combined with Vinorelbine. |
Golimumab Injection | Golimumab Injection The metabolism of Golimumab can be increased when combined with Vinorelbine. |
Pazopanib | Pazopanib The metabolism of Pazopanib can be decreased when combined with Vinorelbine. |
Asenapine | Asenapine Vinorelbine may increase the neurotoxic activities of Asenapine. |
Albendazole | Albendazole The metabolism of Vinorelbine can be decreased when combined with Albendazole. |
Oxymorphone | Oxymorphone The metabolism of Oxymorphone can be decreased when combined with Vinorelbine. |
Denosumab Injection | Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Vinorelbine. |
Dabigatran | Dabigatran The risk or severity of bleeding can be increased when Dabigatran is combined with Vinorelbine. |
Tocilizumab Injection | Tocilizumab Injection The metabolism of Tocilizumab can be increased when combined with Vinorelbine. |
Fingolimod | Fingolimod Vinorelbine may increase the immunosuppressive activities of Fingolimod. |
Eribulin Injection | Eribulin Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Eribulin. |
Cabazitaxel Injection | Cabazitaxel Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Cabazitaxel. |
Lurasidone | Lurasidone Vinorelbine may increase the neurotoxic activities of Lurasidone. |
Acetaminophen Injection | Acetaminophen Injection The metabolism of Acetaminophen can be increased when combined with Vinorelbine. |
Vilazodone | Vilazodone The metabolism of Vilazodone can be decreased when combined with Vinorelbine. |
Denileukin Diftitox Injection | Denileukin Diftitox Injection The metabolism of Vinorelbine can be decreased when combined with Aldesleukin. |
Sipuleucel-T Injection | Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Vinorelbine. |
Belimumab Injection | Belimumab Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Belimumab. |
Busulfan Injection | Busulfan Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Busulfan. |
Roflumilast | Roflumilast Roflumilast may increase the immunosuppressive activities of Vinorelbine. |
Linagliptin | Linagliptin The metabolism of Vinorelbine can be decreased when combined with Linagliptin. |
Rilpivirine | Rilpivirine The metabolism of Vinorelbine can be decreased when combined with Rilpivirine. |
Telaprevir | Telaprevir The metabolism of Vinorelbine can be decreased when combined with Glecaprevir. |
Cyclophosphamide Injection | Cyclophosphamide Injection The metabolism of Cyclophosphamide can be increased when combined with Vinorelbine. |
Rivaroxaban | Rivaroxaban The risk or severity of bleeding can be increased when Rivaroxaban is combined with Vinorelbine. |
Ticagrelor | Ticagrelor The metabolism of Vinorelbine can be decreased when combined with Ticagrelor. |
Brentuximab Vedotin Injection | Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Vinorelbine. |
Ruxolitinib | Ruxolitinib The risk or severity of adverse effects can be increased when Vinorelbine is combined with Ruxolitinib. |
Clobazam | Clobazam The metabolism of Vinorelbine can be increased when combined with Clobazam. |
Vemurafenib | Vemurafenib The metabolism of Vinorelbine can be increased when combined with Vemurafenib. |
Belatacept Injection | Belatacept Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Belatacept. |
Ivacaftor | Ivacaftor The metabolism of Vinorelbine can be decreased when combined with Ivacaftor. |
Basiliximab Injection | Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Vinorelbine. |
Crizotinib | Crizotinib The metabolism of Vinorelbine can be decreased when combined with Crizotinib. |
Melphalan Injection | Melphalan Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Melphalan. |
Cabergoline | Cabergoline The metabolism of Vinorelbine can be decreased when combined with Cabergoline. |
Naloxone Injection | Naloxone Injection The metabolism of Vinorelbine can be decreased when combined with Naloxone. |
Eculizumab Injection | Eculizumab Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Eculizumab. |
Fondaparinux Injection | Fondaparinux Injection The risk or severity of bleeding can be increased when Fondaparinux is combined with Vinorelbine. |
Pertuzumab Injection | Pertuzumab Injection The risk or severity of cardiotoxicity can be increased when Vinorelbine is combined with Pertuzumab. |
Carfilzomib Injection | Carfilzomib Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Carfilzomib. |
Iloprost | Iloprost The risk or severity of bleeding can be increased when Iloprost is combined with Vinorelbine. |
Enzalutamide | Enzalutamide The metabolism of Vinorelbine can be increased when combined with Enzalutamide. |
Mirabegron | Mirabegron The metabolism of Mirabegron can be decreased when combined with Vinorelbine. |
Regorafenib | Regorafenib The metabolism of Vinorelbine can be decreased when combined with Regorafenib. |
Bosutinib | Bosutinib The metabolism of Bosutinib can be decreased when combined with Vinorelbine. |
Corticotropin, Repository Injection | Corticotropin, Repository Injection The metabolism of Corticotropin can be increased when combined with Vinorelbine. |
Teriflunomide | Teriflunomide The risk or severity of adverse effects can be increased when Vinorelbine is combined with Teriflunomide. |
Icosapent Ethyl | Icosapent Ethyl The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Vinorelbine. |
Tofacitinib | Tofacitinib Vinorelbine may increase the immunosuppressive activities of Tofacitinib. |
Alogliptin | Alogliptin The metabolism of Alogliptin can be decreased when combined with Vinorelbine. |
Dimethyl Fumarate | Dimethyl Fumarate The risk or severity of adverse effects can be increased when Vinorelbine is combined with Dimethyl fumarate. |
Ponatinib | Ponatinib The metabolism of Ponatinib can be decreased when combined with Vinorelbine. |
Pomalidomide | Pomalidomide The risk or severity of adverse effects can be increased when Vinorelbine is combined with Pomalidomide. |
Ado-trastuzumab Emtansine Injection | Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Vinorelbine. |
Apixaban | Apixaban The risk or severity of bleeding can be increased when Apixaban is combined with Vinorelbine. |
Dabrafenib | Dabrafenib The metabolism of Vinorelbine can be increased when combined with Dabrafenib. |
Trametinib | Trametinib The metabolism of Vinorelbine can be increased when combined with Trametinib. |
Levomilnacipran | Levomilnacipran The metabolism of Levomilnacipran can be decreased when combined with Vinorelbine. |
Vortioxetine | Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Vinorelbine. |
Perampanel | Perampanel The metabolism of Vinorelbine can be increased when combined with Perampanel. |
Ibrutinib | Ibrutinib The risk or severity of adverse effects can be increased when Vinorelbine is combined with Ibrutinib. |
Lomitapide | Lomitapide The metabolism of Vinorelbine can be decreased when combined with Lomitapide. |
Obinutuzumab Injection | Obinutuzumab Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Obinutuzumab. |
Simeprevir | Simeprevir The metabolism of Vinorelbine can be decreased when combined with Simeprevir. |
Dapagliflozin | Dapagliflozin The metabolism of Dapagliflozin can be decreased when combined with Vinorelbine. |
Apremilast | Apremilast The metabolism of Apremilast can be increased when combined with Vinorelbine. |
Ceritinib | Ceritinib The metabolism of Vinorelbine can be decreased when combined with Ceritinib. |
Siltuximab Injection | Siltuximab Injection The metabolism of Siltuximab can be increased when combined with Vinorelbine. |
Eslicarbazepine | Eslicarbazepine The metabolism of Vinorelbine can be increased when combined with Eslicarbazepine. |
Vedolizumab Injection | Vedolizumab Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Vedolizumab. |
Belinostat Injection | Belinostat Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Belinostat. |
Idelalisib | Idelalisib The risk or severity of adverse effects can be increased when Idelalisib is combined with Vinorelbine. |
Testosterone Injection | Testosterone Injection The metabolism of Vinorelbine can be increased when combined with Testosterone. |
Oritavancin Injection | Oritavancin Injection The metabolism of Vinorelbine can be increased when combined with Oritavancin. |
Vorapaxar | Vorapaxar The metabolism of Vinorelbine can be decreased when combined with Vorapaxar. |
Hydrocodone | Hydrocodone The metabolism of Hydrocodone can be decreased when combined with Vinorelbine. |
Suvorexant | Suvorexant The metabolism of Vinorelbine can be decreased when combined with Suvorexant. |
Edoxaban | Edoxaban The risk or severity of bleeding can be increased when Edoxaban is combined with Vinorelbine. |
Peginterferon Beta-1a Injection | Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Peginterferon beta-1a. |
Olaparib | Olaparib The metabolism of Olaparib can be decreased when combined with Vinorelbine. |
Blinatumomab Injection | Blinatumomab Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Blinatumomab. |
Methamphetamine | Methamphetamine The metabolism of Metamfetamine can be decreased when combined with Vinorelbine. |
Tasimelteon | Tasimelteon The metabolism of Vinorelbine can be decreased when combined with Tasimelteon. |
Lanreotide Injection | Lanreotide Injection The metabolism of Vinorelbine can be decreased when combined with Lanreotide. |
Pirfenidone | Pirfenidone The risk or severity of adverse effects can be increased when Vinorelbine is combined with Pirfenidone. |
Nintedanib | Nintedanib The metabolism of Vinorelbine can be decreased when combined with Nintedanib. |
Secukinumab Injection | Secukinumab Injection The metabolism of Secukinumab can be increased when combined with Vinorelbine. |
Risperidone Injection | Risperidone Injection The metabolism of Risperidone can be decreased when combined with Vinorelbine. |
Palbociclib | Palbociclib The metabolism of Palbociclib can be decreased when combined with Vinorelbine. |
Lenvatinib | Lenvatinib The metabolism of Vinorelbine can be increased when combined with Lenvatinib. |
Panobinostat | Panobinostat The risk or severity of adverse effects can be increased when Vinorelbine is combined with Panobinostat. |
Dinutuximab Injection | Dinutuximab Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Dinutuximab. |
Haloperidol Injection | Haloperidol Injection The serum concentration of Haloperidol can be increased when it is combined with Vinorelbine. |
Isavuconazonium Injection | Isavuconazonium Injection The metabolism of Vinorelbine can be increased when combined with Isavuconazonium. |
Prednisolone | Prednisolone The metabolism of Prednisolone can be increased when combined with Vinorelbine. |
Brexpiprazole | Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Vinorelbine. |
Ziprasidone Injection | Ziprasidone Injection The metabolism of Vinorelbine can be decreased when combined with Ziprasidone. |
Cariprazine | Cariprazine The metabolism of Cariprazine can be decreased when combined with Vinorelbine. |
Cobimetinib | Cobimetinib The metabolism of Vinorelbine can be decreased when combined with Cobimetinib. |
Mepolizumab Injection | Mepolizumab Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Mepolizumab. |
Trabectedin Injection | Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Vinorelbine. |
Osimertinib | Osimertinib The metabolism of Vinorelbine can be increased when combined with Osimertinib. |
Rifapentine | Rifapentine The metabolism of Vinorelbine can be increased when combined with Rifapentine. |
Lesinurad | Lesinurad The metabolism of Vinorelbine can be increased when combined with Lesinurad. |
Amphotericin B Liposomal Injection | Amphotericin B Liposomal Injection The metabolism of Vinorelbine can be decreased when combined with Amphotericin B. |
Dexamethasone Injection | Dexamethasone Injection The metabolism of Dexamethasone can be increased when combined with Vinorelbine. |
Defibrotide Injection | Defibrotide Injection The risk or severity of bleeding can be increased when Defibrotide is combined with Vinorelbine. |
Ixekizumab Injection | Ixekizumab Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Ixekizumab. |
Venetoclax | Venetoclax The metabolism of Vinorelbine can be decreased when combined with Venetoclax. |
Cobicistat | Cobicistat The metabolism of Vinorelbine can be decreased when combined with Cobicistat. |
Pimavanserin | Pimavanserin Vinorelbine may increase the neurotoxic activities of Pimavanserin. |
Diphenhydramine Injection | Diphenhydramine Injection The metabolism of Diphenhydramine can be decreased when combined with Vinorelbine. |
Rucaparib | Rucaparib The metabolism of Rucaparib can be decreased when combined with Vinorelbine. |
Ribociclib | Ribociclib The metabolism of Vinorelbine can be decreased when combined with Ribociclib. |
Brodalumab Injection | Brodalumab Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Brodalumab. |
Brigatinib | Brigatinib The metabolism of Vinorelbine can be increased when combined with Brigatinib. |
Doxepin (Insomnia) | Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Vinorelbine. |
Deutetrabenazine | Deutetrabenazine The metabolism of Deutetrabenazine can be decreased when combined with Vinorelbine. |
Valbenazine | Valbenazine The metabolism of Valbenazine can be decreased when combined with Vinorelbine. |
Deflazacort | Deflazacort The metabolism of Deflazacort can be increased when combined with Vinorelbine. |
Ocrelizumab Injection | Ocrelizumab Injection Ocrelizumab may increase the immunosuppressive activities of Vinorelbine. |
Sarilumab Injection | Sarilumab Injection The metabolism of Sarilumab can be increased when combined with Vinorelbine. |
Midostaurin | Midostaurin The metabolism of Vinorelbine can be increased when combined with Midostaurin. |
Guselkumab Injection | Guselkumab Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Guselkumab. |
Enasidenib | Enasidenib The metabolism of Enasidenib can be increased when combined with Vinorelbine. |
Aprepitant/Fosaprepitant Injection | Aprepitant/Fosaprepitant Injection The metabolism of Vinorelbine can be increased when combined with Fosaprepitant. |
Betrixaban | Betrixaban The risk or severity of bleeding can be increased when Betrixaban is combined with Vinorelbine. |
Acalabrutinib | Acalabrutinib The metabolism of Vinorelbine can be decreased when combined with Acalabrutinib. |
Gemtuzumab Ozogamicin Injection | Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Vinorelbine. |
Letermovir | Letermovir The metabolism of Letermovir can be decreased when combined with Vinorelbine. |
Tetrabenazine | Tetrabenazine The metabolism of Tetrabenazine can be decreased when combined with Vinorelbine. |
Buprenorphine Injection | Buprenorphine Injection The metabolism of Buprenorphine can be decreased when combined with Vinorelbine. |
Apalutamide | Apalutamide The metabolism of Vinorelbine can be increased when combined with Apalutamide. |
Penicillamine | Penicillamine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Penicillamine. |
Fostamatinib | Fostamatinib The metabolism of Vinorelbine can be decreased when combined with Fostamatinib. |
Baricitinib | Baricitinib The risk or severity of adverse effects can be increased when Vinorelbine is combined with Baricitinib. |
Lofexidine | Lofexidine The metabolism of Lofexidine can be decreased when combined with Vinorelbine. |
Eliglustat | Eliglustat The metabolism of Eliglustat can be decreased when combined with Vinorelbine. |
Encorafenib | Encorafenib The metabolism of Encorafenib can be decreased when combined with Vinorelbine. |
Ivosidenib | Ivosidenib The metabolism of Vinorelbine can be increased when combined with Ivosidenib. |
Elagolix | Elagolix The metabolism of Elagolix can be decreased when combined with Vinorelbine. |
Tafenoquine | Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Vinorelbine. |
Dacomitinib | Dacomitinib The metabolism of Dacomitinib can be decreased when combined with Vinorelbine. |
Duvelisib | Duvelisib The metabolism of Vinorelbine can be decreased when combined with Duvelisib. |
Stiripentol | Stiripentol The metabolism of Vinorelbine can be decreased when combined with Stiripentol. |
Gilteritinib | Gilteritinib The metabolism of Vinorelbine can be decreased when combined with Gilteritinib. |
Methoxy Polyethylene Glycol-Epoetin Beta Injection | Methoxy Polyethylene Glycol-Epoetin Beta Injection The risk or severity of peripheral neuropathy can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Vinorelbine. |
Paclitaxel (with albumin) Injection | Paclitaxel (with albumin) Injection Paclitaxel may increase the neurotoxic activities of Vinorelbine. |
Rifamycin | Rifamycin The metabolism of Vinorelbine can be increased when combined with Rifamycin. |
Prucalopride | Prucalopride The metabolism of Vinorelbine can be decreased when combined with Prucalopride. |
Ravulizumab-cwvz Injection | Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Ravulizumab. |
Emapalumab-lzsg Injection | Emapalumab-lzsg Injection The metabolism of Emapalumab can be increased when combined with Vinorelbine. |
Siponimod | Siponimod The risk or severity of adverse effects can be increased when Vinorelbine is combined with Siponimod. |
Caplacizumab-yhdp Injection | Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Caplacizumab is combined with Vinorelbine. |
Risankizumab-rzaa Injection | Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Risankizumab. |
Alpelisib | Alpelisib The metabolism of Vinorelbine can be increased when combined with Alpelisib. |
Cladribine | Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Vinorelbine. |
Triclabendazole | Triclabendazole The metabolism of Triclabendazole can be decreased when combined with Vinorelbine. |
Istradefylline | Istradefylline The metabolism of Istradefylline can be decreased when combined with Vinorelbine. |
Pitolisant | Pitolisant The serum concentration of Vinorelbine can be decreased when it is combined with Pitolisant. |
Lefamulin | Lefamulin The serum concentration of Vinorelbine can be increased when it is combined with Lefamulin. |
Phenytoin Injection | Phenytoin Injection The metabolism of Phenytoin can be increased when combined with Vinorelbine. |
Fosphenytoin Injection | Fosphenytoin Injection The metabolism of Vinorelbine can be increased when combined with Fosphenytoin. |
Voxelotor | Voxelotor The serum concentration of Vinorelbine can be increased when it is combined with Voxelotor. |
Tazemetostat | Tazemetostat The metabolism of Vinorelbine can be decreased when combined with Tazemetostat. |
Cenobamate | Cenobamate The serum concentration of Vinorelbine can be decreased when it is combined with Cenobamate. |
Ozanimod | Ozanimod The risk or severity of adverse effects can be increased when Vinorelbine is combined with Ozanimod. |
Tucatinib | Tucatinib The metabolism of Tucatinib can be decreased when combined with Vinorelbine. |
Octreotide | Octreotide The serum concentration of Vinorelbine can be increased when it is combined with Octreotide. |
Pralsetinib | Pralsetinib The metabolism of Vinorelbine can be increased when combined with Pralsetinib. |
Satralizumab-mwge Injection | Satralizumab-mwge Injection The serum concentration of Vinorelbine can be decreased when it is combined with Satralizumab. |
Naxitamab-gqgk Injection | Naxitamab-gqgk Injection Vinorelbine may increase the neurotoxic activities of Naxitamab. |
Progestin-Only (drospirenone) Oral Contraceptives | Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Vinorelbine can be decreased when combined with Drospirenone. |
Vitamin E (Alpha-Tocopherol) | Vitamin E (Alpha-Tocopherol) The metabolism of Vinorelbine can be increased when combined with Vitamin E. |
Theophylline | Theophylline The metabolism of Theophylline can be decreased when combined with Vinorelbine. |
Indomethacin | Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Vinorelbine. |
Trazodone | Trazodone The metabolism of Trazodone can be decreased when combined with Vinorelbine. |
Hydroxyurea | Hydroxyurea The risk or severity of adverse effects can be increased when Vinorelbine is combined with Hydroxyurea. |
Floxuridine | Floxuridine The risk or severity of adverse effects can be increased when Floxuridine is combined with Vinorelbine. |
Phenobarbital | Phenobarbital The metabolism of Vinorelbine can be increased when combined with Phenobarbital. |
Methotrexate Injection | Methotrexate Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Methotrexate. |
Primidone | Primidone The metabolism of Vinorelbine can be increased when combined with Primidone. |
Chlorpromazine | Chlorpromazine The metabolism of Chlorpromazine can be increased when combined with Vinorelbine. |
Diazepam | Diazepam The metabolism of Vinorelbine can be decreased when combined with Diazepam. |
Lorazepam | Lorazepam The metabolism of Vinorelbine can be decreased when combined with Lorazepam. |
Carmustine | Carmustine The risk or severity of adverse effects can be increased when Carmustine is combined with Vinorelbine. |
Codeine | Codeine The metabolism of Codeine can be decreased when combined with Vinorelbine. |
Bromocriptine | Bromocriptine The metabolism of Vinorelbine can be decreased when combined with Bromocriptine. |
Tranylcypromine | Tranylcypromine The metabolism of Vinorelbine can be decreased when combined with Tranylcypromine. |
Phenelzine | Phenelzine The metabolism of Vinorelbine can be decreased when combined with Phenelzine. |
Procarbazine | Procarbazine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Procarbazine. |
Tetracycline | Tetracycline The metabolism of Vinorelbine can be decreased when combined with Tetracycline. |
Thioguanine | Thioguanine The risk or severity of adverse effects can be increased when Tioguanine is combined with Vinorelbine. |
Prochlorperazine | Prochlorperazine The metabolism of Prochlorperazine can be decreased when combined with Vinorelbine. |
Thioridazine | Thioridazine The metabolism of Thioridazine can be decreased when combined with Vinorelbine. |
Trifluoperazine | Trifluoperazine Vinorelbine may increase the neurotoxic activities of Trifluoperazine. |
Bleomycin | Bleomycin The risk or severity of adverse effects can be increased when Bleomycin is combined with Vinorelbine. |
Oxycodone | Oxycodone The metabolism of Oxycodone can be decreased when combined with Vinorelbine. |
Methadone | Methadone The metabolism of Methadone can be increased when combined with Vinorelbine. |
Oxybutynin | Oxybutynin The metabolism of Vinorelbine can be decreased when combined with Oxybutynin. |
Benztropine | Benztropine The metabolism of Benzatropine can be decreased when combined with Vinorelbine. |
Maprotiline | Maprotiline The metabolism of Maprotiline can be decreased when combined with Vinorelbine. |
Orphenadrine | Orphenadrine The metabolism of Vinorelbine can be decreased when combined with Orphenadrine. |
Perphenazine | Perphenazine The metabolism of Perphenazine can be decreased when combined with Vinorelbine. |
Azathioprine | Azathioprine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Azathioprine. |
Fluphenazine | Fluphenazine Vinorelbine may increase the neurotoxic activities of Fluphenazine. |
Phentermine | Phentermine The metabolism of Vinorelbine can be decreased when combined with Phentermine. |
Amoxapine | Amoxapine The metabolism of Amoxapine can be decreased when combined with Vinorelbine. |
Sulfasalazine | Sulfasalazine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Sulfasalazine. |
Hydrocortisone | Hydrocortisone The metabolism of Vinorelbine can be increased when combined with Hydrocortisone. |
Lomustine | Lomustine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Lomustine. |
Doxorubicin | Doxorubicin The metabolism of Doxorubicin can be decreased when combined with Vinorelbine. |
Cytarabine | Cytarabine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Cytarabine. |
Mechlorethamine | Mechlorethamine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Mechlorethamine. |
Dactinomycin | Dactinomycin The risk or severity of adverse effects can be increased when Vinorelbine is combined with Dactinomycin. |
Carbamazepine | Carbamazepine The metabolism of Carbamazepine can be increased when combined with Vinorelbine. |
Molindone | Molindone Vinorelbine may increase the neurotoxic activities of Molindone. |
Clonidine | Clonidine The metabolism of Clonidine can be decreased when combined with Vinorelbine. |
Hydralazine | Hydralazine The metabolism of Vinorelbine can be decreased when combined with Hydralazine. |
Cimetidine | Cimetidine The metabolism of Vinorelbine can be decreased when combined with Cimetidine. |
Warfarin | Warfarin The metabolism of Vinorelbine can be increased when combined with Warfarin. |
Loperamide | Loperamide The metabolism of Loperamide can be decreased when combined with Vinorelbine. |
Promethazine | Promethazine The metabolism of Promethazine can be decreased when combined with Vinorelbine. |
Daunorubicin | Daunorubicin The metabolism of Daunorubicin can be decreased when combined with Vinorelbine. |
Griseofulvin | Griseofulvin The metabolism of Vinorelbine can be increased when combined with Griseofulvin. |
Digoxin | Digoxin Digoxin may decrease the cardiotoxic activities of Vinorelbine. |
Loxapine | Loxapine Vinorelbine may increase the neurotoxic activities of Loxapine. |
Chloroquine | Chloroquine The metabolism of Chloroquine can be decreased when combined with Vinorelbine. |
Quinine | Quinine The metabolism of Quinine can be increased when combined with Vinorelbine. |
Calcitriol | Calcitriol The metabolism of Vinorelbine can be increased when combined with Calcitriol. |
Sulfinpyrazone | Sulfinpyrazone The metabolism of Vinorelbine can be increased when combined with Sulfinpyrazone. |
Chlorothiazide | Chlorothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Vinorelbine. |
Clindamycin Injection | Clindamycin Injection The serum concentration of Clindamycin can be increased when it is combined with Vinorelbine. |
Secobarbital | Secobarbital The metabolism of Vinorelbine can be increased when combined with Secobarbital. |
Desipramine | Desipramine The metabolism of Desipramine can be decreased when combined with Vinorelbine. |
Amitriptyline | Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Vinorelbine. |
Imipramine | Imipramine The metabolism of Imipramine can be decreased when combined with Vinorelbine. |
Probenecid | Probenecid The metabolism of Vinorelbine can be increased when combined with Probenecid. |
Quinidine | Quinidine The metabolism of Quinidine can be decreased when combined with Vinorelbine. |
Procainamide | Procainamide The metabolism of Procainamide can be decreased when combined with Vinorelbine. |
Isoniazid | Isoniazid The metabolism of Vinorelbine can be decreased when combined with Isoniazid. |
Rifampin | Rifampin The metabolism of Vinorelbine can be increased when combined with Rifampicin. |
Valproic Acid | Valproic Acid The metabolism of Vinorelbine can be decreased when combined with Valproic acid. |
Tamoxifen | Tamoxifen The metabolism of Tamoxifen can be increased when combined with Vinorelbine. |
Mitomycin | Mitomycin The risk or severity of bronchospasm, shortness of breath, and dyspnea can be increased when Vinorelbine is combined with Mitomycin. |
Methimazole | Methimazole The metabolism of Methimazole can be decreased when combined with Vinorelbine. |
Propylthiouracil | Propylthiouracil The risk or severity of adverse effects can be increased when Vinorelbine is combined with Propylthiouracil. |
Dextromethorphan | Dextromethorphan The metabolism of Dextromethorphan can be decreased when combined with Vinorelbine. |
Cyclobenzaprine | Cyclobenzaprine Vinorelbine may increase the neurotoxic activities of Cyclobenzaprine. |
Niacin | Niacin The metabolism of Vinorelbine can be decreased when combined with Niacin. |
Chlorpheniramine | Chlorpheniramine The metabolism of Chlorpheniramine can be decreased when combined with Vinorelbine. |
Meclizine | Meclizine The metabolism of Meclizine can be decreased when combined with Vinorelbine. |
Methyclothiazide | Methyclothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Vinorelbine. |
Hydrochlorothiazide | Hydrochlorothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Vinorelbine. |
Chlorzoxazone | Chlorzoxazone The metabolism of Chlorzoxazone can be decreased when combined with Vinorelbine. |
Danazol | Danazol The metabolism of Vinorelbine can be decreased when combined with Danazol. |
Propranolol (Cardiovascular) | Propranolol (Cardiovascular) The metabolism of Propranolol can be decreased when combined with Vinorelbine. |
Nortriptyline | Nortriptyline The metabolism of Nortriptyline can be decreased when combined with Vinorelbine. |
Amphotericin B Injection | Amphotericin B Injection The metabolism of Vinorelbine can be decreased when combined with Amphotericin B. |
Mercaptopurine | Mercaptopurine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Mercaptopurine. |
Nadolol | Nadolol The metabolism of Nadolol can be decreased when combined with Vinorelbine. |
Allopurinol | Allopurinol The risk or severity of adverse effects can be increased when Allopurinol is combined with Vinorelbine. |
Fluorouracil Injection | Fluorouracil Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Fluorouracil. |
Colchicine | Colchicine The metabolism of Colchicine can be increased when combined with Vinorelbine. |
Cephalexin | Cephalexin The metabolism of Vinorelbine can be decreased when combined with Cephalexin. |
Dacarbazine | Dacarbazine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Dacarbazine. |
Acetazolamide | Acetazolamide The metabolism of Vinorelbine can be decreased when combined with Acetazolamide. |
Bacillus Calmette-Guerin (BCG) Vaccine | Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Vinorelbine. |
Ketoconazole | Ketoconazole The metabolism of Vinorelbine can be decreased when combined with Ketoconazole. |
Thiotepa Injection | Thiotepa Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Thiotepa. |
Vincristine Injection | Vincristine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Vincristine. |
Dipyridamole | Dipyridamole The risk or severity of bleeding can be increased when Dipyridamole is combined with Vinorelbine. |
Vinblastine | Vinblastine The metabolism of Vinblastine can be increased when combined with Vinorelbine. |
Metoprolol | Metoprolol The metabolism of Metoprolol can be decreased when combined with Vinorelbine. |
Thiothixene | Thiothixene Vinorelbine may increase the neurotoxic activities of Thiothixene. |
Aspirin | Aspirin The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Vinorelbine. |
Chlorambucil | Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Vinorelbine. |
Diltiazem | Diltiazem The metabolism of Diltiazem can be decreased when combined with Vinorelbine. |
Nifedipine | Nifedipine The metabolism of Nifedipine can be increased when combined with Vinorelbine. |
Timolol | Timolol The metabolism of Timolol can be decreased when combined with Vinorelbine. |
Verapamil | Verapamil The metabolism of Vinorelbine can be decreased when combined with Verapamil. |
Atenolol | Atenolol The metabolism of Atenolol can be decreased when combined with Vinorelbine. |
Pindolol | Pindolol The metabolism of Pindolol can be decreased when combined with Vinorelbine. |
Cisplatin Injection | Cisplatin Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Vinorelbine. |
Streptozocin | Streptozocin The risk or severity of adverse effects can be increased when Vinorelbine is combined with Streptozocin. |
Etoposide | Etoposide The metabolism of Etoposide can be increased when combined with Vinorelbine. |
Glyburide | Glyburide The metabolism of Vinorelbine can be decreased when combined with Glyburide. |
Dicloxacillin | Dicloxacillin The metabolism of Vinorelbine can be increased when combined with Dicloxacillin. |
Nafcillin Injection | Nafcillin Injection The metabolism of Vinorelbine can be increased when combined with Nafcillin. |
Pentoxifylline | Pentoxifylline The risk or severity of bleeding can be increased when Pentoxifylline is combined with Vinorelbine. |
Pentamidine Injection | Pentamidine Injection The metabolism of Pentamidine can be decreased when combined with Vinorelbine. |
Labetalol | Labetalol The metabolism of Labetalol can be decreased when combined with Vinorelbine. |
Pimozide | Pimozide The metabolism of Pimozide can be decreased when combined with Vinorelbine. |
Amiodarone | Amiodarone The metabolism of Vinorelbine can be decreased when combined with Amiodarone. |
Buspirone | Buspirone The metabolism of Buspirone can be decreased when combined with Vinorelbine. |
Lovastatin | Lovastatin The metabolism of Vinorelbine can be decreased when combined with Lovastatin. |
Ciprofloxacin | Ciprofloxacin The metabolism of Vinorelbine can be decreased when combined with Ciprofloxacin. |
Fluoxetine | Fluoxetine The metabolism of Fluoxetine can be decreased when combined with Vinorelbine. |
Interferon Alfa-2b Injection | Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Vinorelbine. |
Clozapine | Clozapine The risk or severity of neutropenia can be increased when Vinorelbine is combined with Clozapine. |
Idarubicin | Idarubicin The risk or severity of adverse effects can be increased when Vinorelbine is combined with Idarubicin. |
Didanosine | Didanosine Vinorelbine may increase the neurotoxic activities of Didanosine. |
Fludarabine Injection | Fludarabine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Fludarabine. |
Pentostatin Injection | Pentostatin Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Pentostatin. |
Clarithromycin | Clarithromycin The metabolism of Vinorelbine can be decreased when combined with Clarithromycin. |
Felodipine | Felodipine The metabolism of Vinorelbine can be decreased when combined with Felodipine. |
Simvastatin | Simvastatin The metabolism of Simvastatin can be decreased when combined with Vinorelbine. |
Filgrastim Injection | Filgrastim Injection The risk or severity of peripheral neuropathy can be increased when Filgrastim is combined with Vinorelbine. |
Epoetin Alfa, Injection | Epoetin Alfa, Injection The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vinorelbine. |
Teniposide Injection | Teniposide Injection The metabolism of Teniposide can be decreased when combined with Vinorelbine. |
Itraconazole | Itraconazole The metabolism of Vinorelbine can be decreased when combined with Itraconazole. |
Sargramostim | Sargramostim The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vinorelbine. |
Rifabutin | Rifabutin The metabolism of Vinorelbine can be increased when combined with Rifabutin. |
Sotalol | Sotalol The metabolism of Sotalol can be decreased when combined with Vinorelbine. |
Zolpidem | Zolpidem The metabolism of Zolpidem can be decreased when combined with Vinorelbine. |
Doxazosin | Doxazosin The metabolism of Doxazosin can be decreased when combined with Vinorelbine. |
Isradipine | Isradipine The metabolism of Vinorelbine can be decreased when combined with Isradipine. |
Omeprazole | Omeprazole The metabolism of Vinorelbine can be increased when combined with Omeprazole. |
Cisapride | Cisapride The metabolism of Vinorelbine can be decreased when combined with Cisapride. |
Fluvastatin | Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Vinorelbine. |
Venlafaxine | Venlafaxine The metabolism of Venlafaxine can be decreased when combined with Vinorelbine. |
Stavudine | Stavudine Vinorelbine may increase the neurotoxic activities of Stavudine. |
Famciclovir | Famciclovir The metabolism of Vinorelbine can be decreased when combined with Famciclovir. |
Fluvoxamine | Fluvoxamine The metabolism of Fluvoxamine can be decreased when combined with Vinorelbine. |
Nefazodone | Nefazodone The metabolism of Nefazodone can be decreased when combined with Vinorelbine. |
Losartan | Losartan The metabolism of Vinorelbine can be decreased when combined with Losartan. |
Tramadol | Tramadol The metabolism of Vinorelbine can be decreased when combined with Tramadol. |
Carboplatin Injection | Carboplatin Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Carboplatin. |
Lansoprazole | Lansoprazole The metabolism of Vinorelbine can be increased when combined with Lansoprazole. |
Ifosfamide Injection | Ifosfamide Injection The metabolism of Ifosfamide can be increased when combined with Vinorelbine. |
Pegaspargase Injection | Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Vinorelbine. |
Nicardipine | Nicardipine The metabolism of Vinorelbine can be decreased when combined with Nicardipine. |
Ticlopidine | Ticlopidine The metabolism of Ticlopidine can be decreased when combined with Vinorelbine. |
Saquinavir | Saquinavir The metabolism of Vinorelbine can be decreased when combined with Saquinavir. |
Dalteparin Injection | Dalteparin Injection The risk or severity of bleeding can be increased when Dalteparin is combined with Vinorelbine. |
Anastrozole | Anastrozole The risk or severity of cardiotoxicity can be increased when Vinorelbine is combined with Anastrozole. |
Gemcitabine Injection | Gemcitabine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Gemcitabine. |
Ritonavir | Ritonavir The serum concentration of Ritonavir can be increased when it is combined with Vinorelbine. |
Docetaxel Injection | Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Vinorelbine. |
Clomipramine | Clomipramine The metabolism of Clomipramine can be decreased when combined with Vinorelbine. |
Zafirlukast | Zafirlukast The metabolism of Vinorelbine can be decreased when combined with Zafirlukast. |
Mirtazapine | Mirtazapine The metabolism of Mirtazapine can be decreased when combined with Vinorelbine. |
Topiramate | Topiramate The metabolism of Vinorelbine can be increased when combined with Topiramate. |
Donepezil | Donepezil The metabolism of Donepezil can be decreased when combined with Vinorelbine. |
Azithromycin | Azithromycin The metabolism of Vinorelbine can be decreased when combined with Azithromycin. |
Carvedilol | Carvedilol The metabolism of Carvedilol can be decreased when combined with Vinorelbine. |
Selegiline | Selegiline The metabolism of Selegiline can be decreased when combined with Vinorelbine. |
Bicalutamide | Bicalutamide The metabolism of Vinorelbine can be decreased when combined with Bicalutamide. |
Sertraline | Sertraline The metabolism of Sertraline can be decreased when combined with Vinorelbine. |
Propafenone | Propafenone The metabolism of Propafenone can be decreased when combined with Vinorelbine. |
Raloxifene | Raloxifene The metabolism of Vinorelbine can be decreased when combined with Raloxifene. |
Irbesartan | Irbesartan The metabolism of Vinorelbine can be decreased when combined with Irbesartan. |
Tamsulosin | Tamsulosin The metabolism of Tamsulosin can be decreased when combined with Vinorelbine. |
Quetiapine | Quetiapine The metabolism of Quetiapine can be decreased when combined with Vinorelbine. |
Paroxetine | Paroxetine The metabolism of Paroxetine can be decreased when combined with Vinorelbine. |
Citalopram | Citalopram The metabolism of Citalopram can be decreased when combined with Vinorelbine. |
Capecitabine | Capecitabine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Capecitabine. |
Efavirenz | Efavirenz The metabolism of Vinorelbine can be increased when combined with Efavirenz. |
Sildenafil | Sildenafil The metabolism of Sildenafil can be decreased when combined with Vinorelbine. |
Trastuzumab Injection | Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Vinorelbine. |
Celecoxib | Celecoxib The metabolism of Celecoxib can be decreased when combined with Vinorelbine. |
Tolterodine | Tolterodine The metabolism of Tolterodine can be decreased when combined with Vinorelbine. |
Thalidomide | Thalidomide The risk or severity of adverse effects can be increased when Vinorelbine is combined with Thalidomide. |
Nateglinide | Nateglinide The metabolism of Nateglinide can be decreased when combined with Vinorelbine. |
Galantamine | Galantamine The metabolism of Galantamine can be decreased when combined with Vinorelbine. |
Rabeprazole | Rabeprazole The metabolism of Vinorelbine can be decreased when combined with Rabeprazole. |
Terbinafine | Terbinafine The metabolism of Vinorelbine can be increased when combined with Terbinafine. |
Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists